KR101083524B1 - Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup - Google Patents
Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup Download PDFInfo
- Publication number
- KR101083524B1 KR101083524B1 KR1020110071360A KR20110071360A KR101083524B1 KR 101083524 B1 KR101083524 B1 KR 101083524B1 KR 1020110071360 A KR1020110071360 A KR 1020110071360A KR 20110071360 A KR20110071360 A KR 20110071360A KR 101083524 B1 KR101083524 B1 KR 101083524B1
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- ginseng
- syrup
- rice
- glutinous rice
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 131
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 83
- 235000009566 rice Nutrition 0.000 title claims abstract description 83
- 235000020357 syrup Nutrition 0.000 title claims abstract description 83
- 239000006188 syrup Substances 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims description 42
- 235000009508 confectionery Nutrition 0.000 title claims description 36
- 235000014510 cooky Nutrition 0.000 title abstract 4
- 230000008569 process Effects 0.000 title description 8
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 82
- 241000208340 Araliaceae Species 0.000 claims abstract description 71
- 235000008434 ginseng Nutrition 0.000 claims abstract description 69
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 68
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 68
- 235000000346 sugar Nutrition 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 17
- 238000010025 steaming Methods 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 230000032683 aging Effects 0.000 claims abstract description 3
- 239000008103 glucose Substances 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 238000004898 kneading Methods 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 230000005070 ripening Effects 0.000 claims 1
- 235000019640 taste Nutrition 0.000 abstract description 9
- 238000009835 boiling Methods 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 5
- 235000013339 cereals Nutrition 0.000 abstract 7
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000007598 dipping method Methods 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 238000007781 pre-processing Methods 0.000 abstract 1
- 238000004080 punching Methods 0.000 abstract 1
- 235000013322 soy milk Nutrition 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 16
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 14
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 13
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 13
- 230000000052 comparative effect Effects 0.000 description 12
- 101710111444 Nitric oxide synthase, brain Proteins 0.000 description 10
- 102100022397 Nitric oxide synthase, brain Human genes 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 9
- UEZWWYVAHKTISC-JZKKDOLYSA-N NC(=N)NCCC[C@@H](C(O)=O)NCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO UEZWWYVAHKTISC-JZKKDOLYSA-N 0.000 description 9
- BNRNXUUZRGQAQC-UHFFFAOYSA-N Sildenafil Natural products CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 9
- DLFIWFDONDYZKI-LDDAIVOZSA-N arginyl-fructose Natural products NC(N)=NCCC[C@H](NC[C@@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O)C(O)=O DLFIWFDONDYZKI-LDDAIVOZSA-N 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- DEIYFTQMQPDXOT-UHFFFAOYSA-N sildenafil citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 DEIYFTQMQPDXOT-UHFFFAOYSA-N 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 229940094720 viagra Drugs 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229930182494 ginsenoside Natural products 0.000 description 8
- 229930182490 saponin Natural products 0.000 description 8
- 150000007949 saponins Chemical group 0.000 description 8
- 235000017709 saponins Nutrition 0.000 description 8
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 7
- 238000010171 animal model Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 208000010228 Erectile Dysfunction Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 201000001881 impotence Diseases 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 235000020710 ginseng extract Nutrition 0.000 description 4
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101100296726 Caenorhabditis elegans pde-5 gene Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 3
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940043353 maltol Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 2
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000006180 TBST buffer Substances 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- DIJCILWNOLHJCG-UHFFFAOYSA-N 7-amino-2',7'-difluoro-3',6'-dihydroxy-6-(methylamino)spiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound C12=CC(F)=C(O)C=C2OC2=CC(O)=C(F)C=C2C21OC(=O)C1=C(N)C(NC)=CC=C21 DIJCILWNOLHJCG-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 101000937129 Drosophila melanogaster Cadherin-related tumor suppressor Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 1
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 1
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- YQKCHRBAJSATCG-UHFFFAOYSA-N UNPD30744 Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC(C)(CCC=C(C)C)C2C3C(C4(CCC5C(C)(C)C(OC6C(C(O)C(O)C(CO)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CC3O)C)(C)CC2)O1 YQKCHRBAJSATCG-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000009702 cancer cell proliferation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000005226 corpus cavernosum Anatomy 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 1
- NODILNFGTFIURN-USYOXQFSSA-N ginsenoside Rb3 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-USYOXQFSSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- UVBLDLGZDSGCSN-UHFFFAOYSA-N ginsenoside-Rb3 Natural products C1=CC2C3(C)CCC(O)C(C)(C)C3CCC2(C)C2(C)CCC34CCC(C)C(C)C4C21OC3=O UVBLDLGZDSGCSN-UHFFFAOYSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 1
- 229950000964 pepstatin Drugs 0.000 description 1
- 108010091212 pepstatin Proteins 0.000 description 1
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- IHIXIJGXTJIKRB-UHFFFAOYSA-N trisodium vanadate Chemical compound [Na+].[Na+].[Na+].[O-][V]([O-])([O-])=O IHIXIJGXTJIKRB-UHFFFAOYSA-N 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 1
- REZGGXNDEMKIQB-UHFFFAOYSA-N zaprinast Chemical compound CCCOC1=CC=CC=C1C1=NC(=O)C2=NNNC2=N1 REZGGXNDEMKIQB-UHFFFAOYSA-N 0.000 description 1
- 229950005371 zaprinast Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/0002—Processes of manufacture not relating to composition and compounding ingredients
- A23G3/0004—Processes specially adapted for manufacture or treatment of sweetmeats or confectionery
- A23G3/0006—Manufacture or treatment of liquids, pastes, creams, granules, shred or powder
- A23G3/001—Mixing, kneading processes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/20—Malt products
- A23L7/25—Fermentation of cereal malt or of cereal by malting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 홍삼 한과의 제조방법에 관한 것으로, 보다 구체적으로 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing red ginseng confectionery, and more particularly, to a method of manufacturing red ginseng confection using red ginseng rice syrup.
인삼은 가공방법에 따라 수삼, 백삼, 홍삼으로 나뉜다. 수삼(水蔘)은 보통 4 ~ 6년 재배 후 채굴한 가공하지 않은 상태의 인삼으로 75%의 수분을 함유한 생삼을 말한다. 백삼은 수삼을 찌지 않고 표피를 제거하여 건조한 인삼이다. 홍삼(紅蔘)은 4 ~ 6년근 수삼을 선별하여 껍질을 벗기지 않은 채 증기로 쪄서 건조한 담황갈색 또는 담적갈색의 인삼으로 10년 이상 장기보관이 가능하다. Ginseng is divided into ginseng, white ginseng and red ginseng according to processing method. Fresh ginseng (水 蔘) is raw ginseng that is mined after 4-6 years of cultivation and contains 75% water. White ginseng is dried ginseng by removing the epidermis without steaming ginseng. Red ginseng (紅 蔘) is selected from 4 to 6 years old ginseng and steamed without peeling. It is dried pale yellow brown or light red brown ginseng that can be stored for longer than 10 years.
홍삼은 인삼을 장기간 보관할 수 있을 뿐만 아니라 제조과정 중 증숙(蒸熟)을 거치는 동안 우리 몸에 이로운 여러 가지 생리활성성분들이 생성되는 특징이 있다. 홍삼 제조과정에서는 사포닌(ginsenoside)의 열분해에 의한 부분적인 분자구조의 변화로 화학적인 성분이 변화되어 유익한 특수 성분이 생기게 되는데, 수삼이나 백삼 등에는 포함되어 있지 않은 말톨(Maltol), 진세노사이드 Rg3, Rg2, Rh1 등의 특유성분이 들어있는데, 이 중 말톨(Maltol)은 항암 및 노화억제기능을, 진세노사이드는 암세포증식억제, 항산화 및 항종양의 기능을 가진 생리활성성분으로 알려져 있다.Red ginseng is not only able to store ginseng for a long time, but also has various physiologically active ingredients that are beneficial to our body during the steaming process. In the manufacturing process of red ginseng, the chemical composition is changed due to the partial molecular structure change by the thermal decomposition of saponin (ginsenoside), resulting in beneficial special ingredients. Maltol, ginsenoside Rg3, which is not included in ginseng or white ginseng, etc. , Rg2, Rh1 and other unique ingredients, such as maltol (Maltol) is anti-cancer and anti-aging function, ginsenoside is known as a biologically active ingredient with cancer cell proliferation inhibitory, antioxidant and anti-tumor function.
홍삼은 원재료가 인삼인 것으로 인삼에는 진세노사이드라는 사포닌 물질이 여러 종류로 다량 함유되어있고, 이들 진세노사이드가 각각 자양강장 이외에 불안신경증, 불면, 우울상태 등 중추신경의 증상개선효과, 학습기능의 증진과 기억력을 개선시켜 지적 수행능력을 향상시키는 효능, 외적 유해인자에 대한 비특이적 생체저항력을 증진시켜 주며, 물리적, 화학적, 생물학적인 외적 변화에 대하여 생체를 정상화시켜 주며 혈당강하기능, 해독 촉진작용, 간 손상보호 및 간 재생회복 촉진작용, 심근 세포 보호작용 및 심기능 강화작용, 혈중콜레스테롤의 함량저하 작용, 혈압조절작용 암세포전이와 항암제의 내성형성을 억제하는 활성효과 등의 다양한 약리효능이 있으므로 인삼은 예로부터 한약재로 널리 쓰였으나 최근에는 건강식품으로 다양한 가공식품이 제조되어 소비되고 있다.Red ginseng contains ginseng as a raw material, and ginseng contains a large amount of saponin substance called ginsenoside, and each of these ginsenosides improves symptoms of central nervous system such as anxiety, insomnia, depression, and depression in addition to nourishing tonic. Efficacy in improving intellectual performance by improving memory and memory, improve nonspecific bio-resistance against external harmful factors, normalize living body against physical, chemical, and biological external changes, enhance blood glucose resistance, and promote detoxification Ginseng because it has various pharmacological effects such as protecting liver damage and promoting liver regeneration, protecting cardiomyocytes and strengthening cardiac function, lowering blood cholesterol content, controlling blood pressure, and activating cancer cell metastasis and inhibiting the formation of resistance to anticancer drugs. Has been widely used as a herbal medicine since ancient times, but recently processed into a variety of health foods. This product has been prepared is consumed.
한과는 제조방법에 따라 유과(강정), 다식, 과편, 숙실과, 유밀과, 정과, 엿강정, 엿 등 여러 종류가 있고, 유과에는 얇게 성형하여 건조한 찹쌀 반죽을 기름에 튀겨 표면에 팽화 쌀을 묻히거나 착색시킨 산자류와 갸름하게 썰어 말린 찹쌀 반죽을 기름에 튀겨 팽화시킨 후 여러 강정 고물을 묻힌 손가락 모양의 강정류가 있다. According to the manufacturing method, there are various kinds of Korean fruits, such as sweets (gangjeong), polyps, over flakes, ripe fruit, milk, sweets, malt jeongjeong, and malt, and thinly formed milk powders are fried in oil to fry puffed rice on the surface. There is a finger-shaped Gangjeong with colored Sanja and thinly sliced dried glutinous rice dough fried in oil and swelled.
특히 한과 제조 과정 중 기름에 튀기는 경우 유통이나 보관과정 중에 사용된 기름의 산패가 진행되어 기름 특유의 찌든 냄새가 발생하여 기호도가 떨어질 뿐만 아니라 기름의 산패물인 과산화물을 섭취하여 대사 장애를 일으키는 등 각종 질병이 발생하는 문제점이 있다.
In particular, when fried in oil during the manufacturing process of Korean confectionery, the rancidity of oil used during distribution or storage progresses, resulting in oily odor, and the preference decreases. There is a problem that occurs.
상기 문제점을 해결하기 위해, 본 발명자는 상기와 같은 효능이 있는 홍삼을 우리 식생활에서 쉽게 접할 수 있도록 하고자 홍삼의 유효성분이 함유된 홍삼 한과의 제조방법을 개발하고, 이에 기초하여 본 발명을 완성하게 되었다.In order to solve the above problems, the present inventors have developed a manufacturing method of the red ginseng Hanwa containing the active ingredient of red ginseng in order to easily access the red ginseng having the above efficacy in our diet, and completed the present invention based on this. .
본 발명의 주된 목적은 홍삼의 유용성분의 첨가와 홍삼 고유의 천연향이 가미됨으로써 한과의 맛과 기능성이 높은 홍삼 한과를 제조하는 방법을 제공하는 데 있다.The main object of the present invention is to provide a method of manufacturing a red ginseng Korean confectionery having a high taste and functionality of the Korean confectionery by adding the useful ingredients of red ginseng and natural flavors unique to the red ginseng.
또한, 본 발명의 또 다른 목적은 상기 홍삼 한과의 제조방법에 의하여 제조된 홍삼 한과를 제공하는 데 있다.
In addition, another object of the present invention is to provide a red ginseng confectionery prepared by the manufacturing method of the red ginseng.
본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명, 청구범위 및 도면에 의해 더욱 명확하게 된다.
Other objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.
본 발명의 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법은, 인삼은 선별한 후 세척하여 전처리하고, 찹쌀은 물에 수침한 후 발효시켜 찹쌀 발효물을 제조한 후 이를 탈수시킨 후 분쇄하여 찹쌀분말을 제조하는 단계, 상기 찹쌀분말에 최종 수분함량이 15 내지 25 %가 되도록 물을 첨가하여 반죽하여 반죽물을 형성하는 단계, 상기 반죽물을 증숙시켜 증숙물을 제조한 후, 이를 반죽기에 넣고 꽈리치기한 뒤, 반대기 성형을 하여 반대기를 제조하는 단계, 상기 반대기를 건조시킨 후, 숙성시킨 뒤 기름으로 튀겨내어 튀긴 반대기를 제조하는 단계, 전통조청과 당액을 중량대비 1 : 0.1 내지 0.3으로 혼합하여 제조한 조청시럽을 상기 전처리한 인삼에 중량대비 4 내지 6 : 1로 첨가한 후 졸여 홍삼 쌀 조청물을 제조하는 단계 및 상기 제조된 홍삼 쌀 조청물과 전통 쌀 조청을 중량 대비 100 내지 60% : 0 내지 40% 비율로 혼합하여 당도가 78 Brix 이상이 될 때까지 졸인 다음, 상기 튀긴 반대기에 골고루 묻힌 다음, 반대기 전체에 튀밥을 묻혀 홍삼 한과를 제조하는 단계를 포함한다.
In the manufacturing method of the red ginseng Korean confection using red ginseng rice syrup of the present invention, ginseng is selected, washed and pretreated, glutinous rice is soaked in water and then fermented to prepare a glutinous rice fermented product, which is then dehydrated and ground to a glutinous rice powder. To prepare a step, kneading by adding water to the final moisture content of the glutinous rice powder to 15 to 25% to form a dough, by steaming the dough to prepare a steamed product, put it in a kneader After the stroke, to form a counter machine by forming a counter machine, the counter machine is dried, and then aged and fried to prepare a fried counter machine, mixed with the traditional syrup and sugar solution 1: 0.1 to 0.3 by weight To prepare the ginseng syrup prepared by the addition of 4 to 6: 1 to the weight of the pre-treated ginseng and then boiled to prepare the red ginseng rice syrup and the prepared red ginseng rice syrup Rice syrup is mixed at a ratio of 100 to 60%: 0 to 40% by weight, and then boiled until the sugar content is 78 Brix or more, and then evenly spread on the fried counterpart, followed by frying rice over the counterpart to prepare red ginseng Steps.
<제1단계> 찹쌀분말 제조단계<Step 1> Glutinous Rice Powder Manufacturing Step
상기 찹쌀은 물에 수침한 후 발효시켜 찹쌀 발효물을 제조한 후, 이를 탈수 시킨 후 분쇄하여 찹쌀분말을 제조한다. 이때, 물에 찹쌀을 수침시킨 후, 22 내지27 ℃에서 3 내지 7일 동안 발효시켜 찹쌀 발효물을 제조한 후, 탈수시킨 다음 분쇄기로 분쇄하여 제조하는 것이 바람직하다.
The glutinous rice is immersed in water and then fermented to produce a glutinous rice fermented product, and then dehydrated and ground to prepare glutinous rice powder. At this time, after immersing the glutinous rice in water, it is fermented for 3 to 7 days at 22 to 27 ℃ to prepare a glutinous rice fermented product, it is preferably dehydrated and then pulverized by a grinder.
<제2단계> 반죽물 형성단계<Second Step> Dough Formation Step
제1단계에서 제조된 찹쌀분말에 물을 첨가하면서 반죽하여 반죽물을 형성한다. 반죽물 형성시, 찹쌀분말은 최종 수분함량이 15 내지 25% 정도가 되도록 물을 첨가한 다음, 반죽하여 반죽물을 형성하는 것이 바람직하다. 이때, 콩 물을 찹쌀분말 중량대비 1 내지 3%를 더 첨가하여 제조할 수 있다.
Kneading while adding water to the glutinous rice powder prepared in the first step to form a dough. When the dough is formed, it is preferable that the glutinous rice powder is added with water so as to have a final moisture content of about 15 to 25%, and then kneaded to form a dough. At this time, the soy water can be prepared by adding 1 to 3% by weight of the glutinous rice powder.
<제3단계> 반대기 제조단계<Step 3> Counter-Production Stage
제2단계의 반죽물을 증숙시켜 증숙물을 제조한 후, 이를 반죽기에 넣고 꽈리치기(방망이 등으로 치는 것)를 한 뒤, 반대기(둥글넓적하게 만드는 조각) 성형을 하여 반대기를 제조한다. 이때, 증숙물은 증기를 이용하여 반죽물을 30 내지 50 분간 증자하여 제조하는 것이 바람직하다.
After steaming the dough of the second step to produce a steamed product, put it into a dough and beat it (beating with a bat, etc.), and then the counter machine (a piece made to make a round) to form a counter machine. At this time, the steamed product is preferably prepared by steaming the dough for 30 to 50 minutes using steam.
<제4단계> 튀긴 반대기 제조단계<Step 4> Fried Counter-Factor Manufacturing Step
제3단계의 반대기를 건조 후, 숙성시킨 뒤 튀겨내어 튀긴 반대기를 제조한다. 이때, 반대기를 1차로 10 내지 12 시간 자연건조한 다음, 40 내지 45℃ 건조기에서 12 내지 16 시간 동안 2차 건조하여 최종 수분함량이 14%로 유지되도록 한 후, 12 내지 18 ℃에서 10 내지 15일 동안 숙성시킨 뒤, 튀겨내어 튀긴 반대기를 제조하는 것이 바람직하다.
After drying the counterpart of the third stage, it is aged and fried to prepare a fried counterpart. At this time, the counter group was first dried naturally for 10 to 12 hours, and then secondly dried in a 40 to 45 ° C. dryer for 12 to 16 hours to maintain a final moisture content of 14%, followed by 10 to 15 days at 12 to 18 ° C. After aging for a while, it is preferable to prepare the fried and fried counterpart.
<제5단계> 홍삼 쌀 조청물 제조단계<Step 5> red ginseng rice syrup
홍삼 쌀 조청물은 전통조청과 당액을 혼합한 후 인삼을 첨가하여 졸여서 제조한다. 이때, 전통조청과 당액을 중량대비 1 : 0.1 내지 0.3으로 혼합하는 것을 특징으로 한다. 여기서, 상기 전통조청과 당액을 중량대비 1 : 0.1 내지 0.3으로 혼합하는 것은 전통조청의 고유한 맛과 향을 부가하여 최종생산물인 홍삼 한과의 맛과 향을 향상시키면서 동시에 전통조청에 부족한 단맛을 부가하기 위함이다. 상기 전통조청과 당액을 중량대비 1 : 0.1 미만으로 혼합할 경우에는 전통조청의 단맛을 당액이 충분히 보충하지 못하여 홍삼 특유의 쓴맛이 많이 남아 있어 어린이나 청소년 등의 소비자가 섭취하는 것을 거부할 수 있으며, 상기 전통조청과 당액을 중량대비 1 : 0.3 초과하여 혼합할 경우에는 장년층이나 노년층 등의 소비자가 당액의 강한 단맛으로 인해 섭취하는 것을 거부할 할 수 있다. 또한, 상기 전통조청은 전통적인 방법으로 제조된 것이며, 전통조청의 제조방법은 당업계에서 일반적으로 제조하는 방법으로 그에 대한 설명은 생략한다. Red ginseng rice syrup is prepared by mixing traditional ginseng and sugar solution and then boiled by adding ginseng. At this time, the traditional crude syrup and the sugar solution is characterized in that 1: 0.1 to 0.3 by weight. Here, mixing the traditional jocheok and the sugar solution in a ratio of 1: 0.1 to 0.3 by weight adds the unique taste and aroma of the traditional chocheok to improve the taste and aroma of the red ginseng Hanga, the final product, and at the same time, adds the sweetness lacking to the traditional chocheok. To do this. When the traditional crude syrup and sugar solution are mixed at less than 1: 0.1 by weight, the sweetness of traditional syrup may not be sufficiently replenished, so the bitterness unique to red ginseng remains, so that consumers such as children and adolescents may refuse to consume it. In addition, when the traditional ginseng and the sugar solution is mixed in excess of 1: 0.3 by weight, the elderly or the elderly may refuse to consume due to the strong sweetness of the sugar solution. In addition, the traditional syrup is prepared by the traditional method, the manufacturing method of the traditional syrup is generally prepared in the art, the description thereof will be omitted.
상기 당액은 포도당, 과당, 말토오스, 자당, 락토오스, 자일리톨 중 어느 하나 또는 둘 이상을 혼합하여 사용하는 것을 특징으로 한다. 바람직하게는 상기 당액으로 포도당을 사용한다. 상기와 같이 전통조청과 당액이 혼합된 것을 조청시럽이라고 한다.The sugar solution is characterized by using any one or two or more of glucose, fructose, maltose, sucrose, lactose, xylitol. Preferably glucose is used as the sugar solution. As described above, a mixture of traditional syrup and sugar solution is called syrup syrup.
선별하여 깨끗이 씻어 전처리한 인삼에 상기 조청시럽을 중량대비 1 : 4 내지 6으로 첨가하는 것을 특징으로 한다. 여기서, 상기 인삼에 조청시럽을 중량대비 1 : 4 내지 6으로 첨가하는 것은 인삼과 조청시럽을 졸이는 과정에서 인삼의 유효성분들이 원활하게 추출되고 증숙에 의해 홍삼으로 변하여 홍삼 한과의 맛과 향을 향상시키기 위함이다. 만약, 인삼에 조청시럽을 중량대비 1 : 4 미만으로 첨가할 경우에는 홍삼 한과의 맛이 저하될 수 있으며, 중량대비 1 : 6 초과하여 첨가할 경우에는 조청시럽이 필요 이상으로 첨가되어 홍삼 한과에 단맛이 강하여 홍삼의 고유한 맛이 저하될 수 있다. 바람직하게는 홍삼 쌀 조청물은 78Brix 이상이 되도록 졸여서 제조할 수 있다.The crude ginseng syrup is added in a ratio of 1: 4 to 6 by weight to the ginseng that is selectively washed and pretreated. Here, adding the ginseng syrup to the ginseng 1: 4 to 6 by weight, the active ingredients of ginseng are smoothly extracted in the process of dissolving ginseng and ginseng syrup and turned into red ginseng by steaming to improve the taste and aroma of red ginseng To do so. If ginseng syrup is added less than 1: 4 to ginseng, the taste of red ginseng may decrease. If it is added more than 1: 6, ginseng syrup is added more than necessary to red ginseng The strong sweetness can reduce the inherent taste of red ginseng. Preferably, the red ginseng rice syrup may be prepared by boiling at least 78 Brix.
이때 조청시럽을 첨가한 후 90 내지 100℃에서 3 내지 12시간 동안 졸이는 것을 특징으로 한다. 상기 인삼에 조청시럽을 첨가한 후 90 내지 100℃에서 3 내지 12시간 동안 졸이는 것은 증숙 과정을 거침으로써 인삼의 내부조직을 연화시켜 홍삼을 제조함과 동시에 홍삼 특유의 유효성분들이 조청물에 원활하게 추출되게 하기 위함이다. In this case, after adding the syrup, it is characterized in that it is boiled for 3 to 12 hours at 90 to 100 ℃. After adding crude syrup to ginseng, dozing at 90 to 100 ° C. for 3 to 12 hours softens the internal structure of ginseng by steaming to produce red ginseng and at the same time, the active ingredients unique to red ginseng smoothly to the syrup. To be extracted.
특히, 상기와 같이 인삼에 조청시럽을 첨가한 후 졸임에 따라, 하기 표 2를 통해 알 수 있듯이 백삼이나 수삼에는 포함되어 있지 않은 사포닌 성분인 진세노사이드 Rg3가 다량 함유되어 있음을 알 수 있다. 이는 수삼을 쪄서 홍삼을 제조할 때와 마찬가지로, 전처리된 인삼에 조청시럽을 첨가하여 졸이는 과정 중 인삼이 증숙되어 홍삼으로 변한 것임을 알 수 있다. 이때 조청시럽을 첨가한 후 90℃ 미만에서 3시간 미만 동안 졸일 경우에는 인삼에서 홍삼으로 변화되지 않을 수 있다. 반면, 100℃ 초과에서 12시간 초과하여 졸일 경우에는 인삼에서 홍삼으로 변하더라도 생성된 AF 및 AFG의 함량이 격감할 수 있을 뿐만 아니라 벤조피렌과 같은 발암물질이 생성될 우려가 있다. 상기와 같이 인삼에 조청시럽을 첨가한 후 졸이는 과정은 수삼으로 홍삼을 제조하는 과정에서 생성되는 물질인 AF(Arginyl-fructose) 및 AFG(Arginyl-fructosyl-glucose) 성분이 다량 생성됨에 따라 본 발명에 의한 홍삼 쌀 조청물을 제조할 수 있다. 본 발명의 제조방법은 기존의 한과 제조방법에서 일반적으로 설탕이나 흰 물엿 또는 이온 물엿을 이용하여 튀밥을 접착시키는 것과 달리, 홍삼 쌀 조청물을 이용하여 튀긴 반대기에 튀밥을 접착시킴으로써 한과 속에 상술한 홍삼의 대표적인 유효성분인 사포닌 특히 진세노사이드 Rg3, Rg2, Rh1 및 Rh2가 함유되도록 하여 유효한 사포닌 성분이 최대한 많이 이용될 수 있도록 하는 등 각종 질병을 예방할 수 있음과 동시에 한과 유통시 가장 문제되는 산패를 방지하는 효과도 얻을 수 있다.
In particular, as added to the ginseng syrup to the ginseng as described above, as shown in Table 2, it can be seen that the ginsenoside Rg3, which is a saponin component not contained in white ginseng or ginseng, is contained in a large amount. This is the same as when manufacturing red ginseng by steaming ginseng, it can be seen that the ginseng is steamed and changed to red ginseng during the boiling process by adding crude syrup to the pretreated ginseng. At this time, after adding the syrup, it may not change from ginseng to red ginseng when boiled for less than 3 hours at less than 90 ℃. On the other hand, when it is sol over 12 hours at more than 100 ℃ to change the content of AF and AFG produced even if the ginseng to red ginseng may decrease significantly, there is a fear that carcinogens such as benzopyrene may be generated. As described above, the addition of the crude syrup to ginseng and the boiling process are carried out in accordance with the present invention, since a large amount of AF (Arginyl-fructose) and AFG (Arginyl-fructosyl-glucose) components, which are produced during the preparation of red ginseng, are produced in ginseng. Red ginseng rice syrup may be prepared. The manufacturing method of the present invention is different from the conventional method of manufacturing a traditional Korean confectionery using sugar, white syrup or ionic syrup, and the red ginseng in the confectionery by adhering the rice to the fried counterpart using red ginseng rice syrup Saponin, a representative active ingredient of ginsenosides, in particular Rg3, Rg2, Rh1 and Rh2 are contained so that the most effective saponin components can be used as much as possible to prevent various diseases, and at the same time prevent the rancidity that is the most troubled in circulation You can also get the effect.
<제6단계> 홍삼 한과 제조단계<Stage 6> Red ginseng Hanwa manufacturing stage
제4단계에서 제조된 튀긴 반대기에 상기 제5단계에서 제조한 홍삼 쌀 조청물을 골고루 묻힌 다음, 튀밥을 전체 골고루 묻혀 홍삼 한과를 제조한다. 이때 홍삼한과의 쓴맛 조절을 위해 홍삼 쌀 조청물과 전통 쌀 조청을 중량 대비 100 ~ 60% : 0~40% 비율로 혼합하여 당도가 78Brix 이상이 될 때까지 졸여 사용한다.
On the fried counterpart prepared in the fourth step, the red ginseng rice syrup prepared in the fifth step is evenly applied, and then the whole rice is evenly buried to prepare the red ginseng confectionery. At this time, red ginseng rice syrup and traditional rice syrup are mixed at a ratio of 100 to 60%: 0 to 40% by weight to adjust the bitter taste of red ginseng hanja until the sugar content is over 78 Brix.
이하, 본 발명의 홍삼 한과의 제조방법을 보다 구체적으로 설명하고자 한다.
Hereinafter, the manufacturing method of the red ginseng Korean confectionery of the present invention will be described in more detail.
본 발명의 홍삼 한과 제조방법에 의하면 홍삼 쌀 조청물을 이용함으로써 한과제조시 기름의 산패로 인한 유해성분 발생 및 이취를 최소화할 수 있다. 또한, 당업계에서 일반적으로 설탕이나 흰 물엿 또는 이온 물엿을 사용하여 한과를 제조하는 것과 달리 전통조청과 당액을 혼합한 조청시럽에 인삼을 졸여 만든 홍삼 쌀 조청물을 제조 및 사용함으로써 홍삼 특유의 쓴맛 및 당액의 강한 단맛을 조절하여 소비자들이 거부감 없이 섭취할 수 있도록 기호도와 건강을 증진시킬 수 있는 효과가 있으며, 홍삼 쌀 조청물을 졸이는 과정에서 인삼이 홍삼으로 변하면서 한과 반죽물과 튀밥을 입히기 위해 사용하는 흰 물엿 등에 백삼 분말, 홍삼추출액 또는 농축액을 첨가하는 기존의 홍삼 한과 제조방법보다 홍삼의 유효성분과 특유의 맛과 향이 더욱 부가되어 기능성과 풍미를 한층 향상시킨 홍삼 한과를 제조할 수 있게 되었다.
According to the red ginseng confectionery manufacturing method of the present invention by using the red ginseng rice syrup, it is possible to minimize the generation of harmful components due to rancidity of oil during the manufacturing of confectionery. In addition, in the art, unlike the preparation of traditional Korean confectionery using sugar, white syrup, or ionic syrup, red ginseng rice syrup made by boiling ginseng in crude syrup mixed with traditional syrup and sugar solution, And by controlling the strong sweetness of the sugar solution has the effect of improving the taste and health so that consumers can ingest without reluctance, ginseng is changed to red ginseng in the process of boiling red ginseng rice syrup to apply hanja dough and rice White ginseng powder, red ginseng extract or concentrate is added to the white syrup to be used, and red ginseng confectionery with improved functional and flavor can be prepared by adding more active ingredients and unique taste and aroma of red ginseng.
도 1은 본 발명의 홍삼 한과 제조방법의 공정도를 나타낸 것이다.
도 2는 본 발명의 제조방법에 의한 홍삼 한과와 기존의 일반 한과의 산화안정성을 비교실험한 결과를 나타낸 그래프이다(control: 일반 한과, Ginseng: 본 발명의 제조방법에 의한 홍삼 한과).
도 3은 실험예 5에 의한 동물모델을 통한 nNOS 및 eNOS 발현결과를 나타낸 것이다(BEG: 흑삼추출물).
도 4는 실험예 5에 의한 동물모델을 통한 산화질소 생성 분석결과를 나타낸 것이다.
도 5는 실험예 5에 의한 동물모델을 통한 cGMP level 분석결과를 나타낸 것이다.Figure 1 shows a process of the red ginseng Hanwa method of the present invention.
Figure 2 is a graph showing the results of the comparative experiments of the oxidation stability of the red ginseng and the conventional common confectionery by the manufacturing method of the present invention (control: general confectionery, Ginseng: red ginseng confectionery by the manufacturing method of the present invention).
Figure 3 shows the nNOS and eNOS expression results through the animal model according to Experimental Example 5 (BEG: black ginseng extract).
Figure 4 shows the results of nitric oxide production analysis through the animal model according to Experimental Example 5.
Figure 5 shows the cGMP level analysis results through the animal model according to Experimental Example 5.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.
Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention in more detail, it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. .
실시예Example 1: 본 발명에 따른 1: According to the present invention 홍삼한과Red Ginseng Han 제조 Produce
(1) 찹쌀 분말 제조(1) glutinous rice powder manufacturing
찹쌀은 강정하기에 적합한 품종인 '아랑향찰'이라는 찹쌀품종을 선택한 후, 이물질을 제거하여 준비해두었다. 찹쌀은 수침한 후, 25 ℃의 온도에서 3 일간 발효시켜 찹쌀 발효물을 제조한 후, 이를 탈수하고 분쇄기(rollermill)를 이용하여 80 mesh로 분쇄하기를 3 회 반복하여 찹쌀분말을 제조하였다. Glutinous rice was prepared by removing the foreign substance after selecting the glutinous rice varieties called 'Arang Hyangcheol' which is a suitable variety to strengthen. The glutinous rice was soaked, fermented for 3 days at a temperature of 25 ℃ to prepare a glutinous rice fermented product, and then dehydrated and milled three times to 80 mesh using a mill (rollermill) to prepare a glutinous rice powder.
(2) 반죽물 형성(2) forming the dough
찹쌀분말에 물을 첨가하여 최종 수분 함량이 20 %정도가 되도록 한 뒤, 반죽하여 반죽물을 형성하였다.Water was added to the glutinous rice powder so that the final moisture content was about 20%, and then kneaded to form a dough.
(3) 반대기 성형(3) counter-forming
형성된 반죽물을 떡시루에 넣고 증기를 이용해 30 분간 충분히 증자한 후, 증자된 반죽을 반죽기에 넣고 75rpm에서 꽈리치기를 한 다음, 꽈리치기한 반죽물이 성형판이나 롤러에 붙지 않도록 옥수수전분을 골고루 도포한 다음 반죽물을 얇게 늘린 후 1×4×0.5 cm 정도의 크기로 절단하여 반대기를 제조하였다.Put the formed dough in the rice cake base and steam it sufficiently for 30 minutes using steam, put the cooked dough into the kneading machine and knead at 75rpm, and apply the corn starch evenly so that the kneaded dough does not stick to the forming plate or roller. Then, the dough was thinly stretched and cut to a size of about 1 × 4 × 0.5 cm to prepare a counter machine.
(4) 튀긴 반대기 제조(4) fried anti-counter manufacture
성형된 반대기를 1 차로 10 시간 자연건조한 다음, 건조기(40 ℃)에서 12 시간 2 차 건조시켜 최종수분함량을 14 %이하로 유지하였다. 그 다음 반대기의 표면부분과 내부의 수분 함량을 균일하게 하여 반대기의 팽창을 좋게 하고 찹쌀반죽의 숙성을 돕기 위해 비닐팩에 반대기를 넣어 밀봉한 후 15 ℃ 온도의 저온실에서 10 일이상 숙성저장시켰다. 그 후 숙성된 반대기를 튀김하는데 1단 튀김온도는 160 ℃이고, 2단 튀김온도는 180 ℃로 하여 튀긴 반대기를 제조하였다.The molded counter-air was first dried naturally for 10 hours and then dried for 2 hours in a dryer (40 ° C.) for 12 hours to maintain a final moisture content of 14% or less. Then, the surface and internal water content of the counter was made uniform to improve the expansion of the counter, and the counter was placed in a plastic pack and sealed in a low temperature room at 15 ℃ for 10 days to improve the maturation of the glutinous rice dough. . Thereafter, to fry the aged counterpart, the first stage frying temperature was 160 ° C., and the second stage frying temperature was 180 ° C. to prepare the fried counterpart.
(5) 홍삼 쌀 조청물 제조(5) Red ginseng rice syrup
홍삼 쌀 조청물은 인삼에 조청과 당액을 혼합한 후 졸여서 제조하였다. 조청과 당액(포도당)을 중량대비 1 : 0.2로 혼합하여 조청시럽을 제조하였다. 선별하여 깨끗이 씻어 전처리한 인삼에 상기 조청시럽을 중량대비 1 : 5로 첨가한 후 90℃에서 6시간 동안 졸여 홍삼 쌀 조청물을 제조하였다.Red ginseng rice syrup was prepared by mixing the ginseng and the sugar solution in ginseng and then boiled. Crude syrup was prepared by mixing the crude syrup and sugar (glucose) in a weight ratio of 1: 0.2. The red ginseng rice syrup was prepared by adding the crude syrup to a weight ratio of 1: 5 to ginseng, washed, and pretreated, and then boiled at 90 ° C. for 6 hours.
(6) 홍삼 한과 제조(6) red ginseng
튀긴 반대기에 묻어있는 기름을 충분히 빼놓는다. 이때 튀긴 반대기에 홍삼 쌀 조청물 100%를 묻힌 다음 튀밥이 골고루 묻히도록 둥글려서 홍삼 한과를 제조하였다.
Remove enough oil from the fried counterpart. At this time, 100% of red ginseng rice syrup was applied to the fried counterpart, and red ginseng was prepared by rounding the rice to be evenly spread.
실시예Example 2 : 본 발명에 따른 2: according to the present invention 홍삼한과Red Ginseng Han 제조 Produce
실시예 1과 같은 방법으로 제조하되, 홍삼 쌀 조청물 제조시 인삼과 조청시럽을 중량대비 1 : 4로 첨가한 후 90℃에서 12시간 동안 졸여 홍삼 쌀 조청물을 제조하고 홍삼 쌀 조청물과 전통 쌀 조청을 중량 대비 80 : 20의 비율로 혼합하여 졸인 다음, 홍삼 한과를 제조하였다.
Prepared in the same manner as in Example 1, but when preparing red ginseng rice syrup, ginseng and syrup syrup was added in a weight ratio of 1: 4, and then boiled at 90 ° C. for 12 hours to prepare red ginseng rice syrup and red ginseng rice syrup Rice syrup was mixed and boiled at a ratio of 80:20 to weight, and then Korean red ginseng was prepared.
실험예Experimental Example 1 : 본 발명에 따른 홍삼 한과의 사포닌 비교분석 1: Comparative Analysis of Saponins of Korean Red Ginseng Herbs According to the Invention
상기와 같이 제조한 실시예 1의 홍삼 한과와 기존의 방법으로 제조한 홍삼한과(비교예 1) 및 기존의 방법으로 제조한 인삼한과(비교예 2)의 조사포닌을 분석한 결과를 하기 표 1에 나타내었다. As a result of analyzing the irradiated pohnponin of the red ginseng Korean family of Example 1 prepared as described above and the red ginseng Korean family (Comparative Example 1) prepared by the conventional method and the conventional ginseng family (Comparative Example 2) Table 1 shows.
실험예Experimental Example 2 : 본 발명에 따른 홍삼 한과의 2: red ginseng Korean family according to the present invention 진세노사이드Gin Senocide 비교분석 comparison analysis
상기와 같이 제조한 실시예 1의 홍삼 한과와 기존의 방법으로 제조한 홍삼한과(비교예 1) 및 기존의 방법으로 제조한 인삼한과(비교예 2)의 진세노사이드 12종을 분석한 결과를 하기 표 2에 나타내었다. Analyzing 12 ginsenosides of the red ginseng Korean family of Example 1 prepared as described above and the red ginseng Korean family (Comparative Example 1) prepared by the conventional method and the ginseng Korean family (Comparative Example 2) prepared by the conventional method The results are shown in Table 2 below.
한과 종류별로 진세노사이드의 양은 극히 소량이어서 비교하기 어려웠으나 실시예 1의 진세노사이드 Rg3는 15.826 mg/g으로 비교예 1(7.563 mg/g) 및 비교예 2(1.088 mg/g)의 기존 제품들보다 2배 이상에서 최대 15배까지 더 많이 함유되어 있음을 알 수 있다. 이는 홍삼 쌀 조청물에 진세노사이드 Rg3가 다량 함유되어 있는 것에서 그 원인을 찾아볼 수 있다. 암세포 전이 억제 작용, 혈소판 응집 억제, 항암제 내성 억제작용을 하는 것으로 알려져 있는 진세노사이드 Rg3(Ginsenoside Rg3)는 수삼이나 백삼에는 거의 들어있지 않고 주로 홍삼에 들어있는 사포닌 성분으로, 본 발명에 따른 제조방법 중에서 홍삼 쌀 조청물 제조단계에서 인삼을 조청시럽과 졸이는 과정에서 인삼 성분이 홍삼으로 변화되어 많은 양이 함유되어 있다는 것을 알 수 있다. 홍삼 쌀 조청물을 이용한 홍삼 한과는 진세노사이드 Rg3를 강화시킨 기능성 홍삼 한과로 볼 수 있을 것이다.The amount of ginsenosides of each type was very small and difficult to compare, but the ginsenoside Rg3 of Example 1 was 15.826 mg / g, which was compared with that of Comparative Example 1 (7.563 mg / g) and Comparative Example 2 (1.088 mg / g). It can be seen that it contains more than 2 times and up to 15 times more than the products. This may be due to the fact that red ginseng rice syrup contains a large amount of ginsenoside Rg3. Ginsenoside Rg3 (Ginsenoside Rg3), which is known to inhibit cancer cell metastasis, inhibit platelet aggregation, and inhibit anticancer drugs, is a saponin component in red ginseng, which is hardly contained in ginseng or white ginseng, and according to the present invention. It can be seen that the ginseng component is changed to red ginseng in the process of preparing red ginseng rice syrup and the ginseng syrup and soaked in ginseng. The red ginseng family using red ginseng rice syrup may be seen as a functional red ginseng family enhanced with ginsenoside Rg3.
실험예Experimental Example 3 : 본 발명에 따른 홍삼 한과의 영양성분 분석 3: Analysis of Nutritional Components of Red Ginseng Korean Fruit According to the Present Invention
상기와 같이 제조한 실시예 1의 홍삼 한과의 영양성분을 분석한 결과를 하기 표 3에 나타내었다. Table 3 shows the results of analyzing the nutritional components of the red ginseng Korean confectionery prepared in Example 1 as described above.
kcal/100g419.16
kcal / 100g
g/100g75.86
g / 100g
g/100g2.02
g / 100g
g/100g11.96
g / 100g
g/100g20.47
g / 100g
g/100g1.58
g / 100g
g/100g0.03
g / 100g
g/100g30.86
g / 100g
g/100g0.56
g / 100g
이상과 같이 본 발명에 따른 홍삼 한과는 기존의 설탕이나 물엿을 대신하여 홍삼 쌀 조청물을 첨가하여 한과를 제조함으로써 일반한과에 함유될 수 없는 홍삼의 유효한 사포닌 성분이 함유됨으로써 기능성이 향상된 한과라 할 수 있다.
As described above, the red ginseng Korean confectionery according to the present invention is added to the traditional sugar or starch syrup, and the red ginseng rice syrup is added to prepare the Korean confectionery. Can be.
실험예Experimental Example 4 : 본 발명에 따른 홍삼 한과의 산화안정성 비교 실험 4: Comparative Experiment of Oxidative Stability of Korean Red Ginseng Roots According to the Present Invention
인삼 성분이 전혀 함유되어 있지 않은 기존의 일반 한과를 대조구(control)로 하고, 본 발명의 제조방법에 의해 제조된 홍삼 한과와의 산화안정성을 다음과 같이 비교 실험하였다.
As a control of the existing general confectionery containing no ginseng components at all, the oxidation stability of the red ginseng confectionery prepared by the manufacturing method of the present invention was compared and tested as follows.
(1) 실험재료(1) Experimental material
실험에 사용한 찹쌀은 충남 금산지역에서 생산된 신선종, 인삼은 충남 금산지역에서 재배한 4년근 수삼, 튀김용 기름은 콩기름(D 유량), 25% 알코올(S 주조), 물엿은 맥아 이온 엿(D 유량)을 사용하였다.
The glutinous rice used in the experiment was Sinseonjong produced in Geumsan, Chungnam, Ginseng was 4 year old ginseng grown in Geumsan, Chungnam, soybean oil (D flow rate), 25% alcohol (S casting), and malt ion malt D flow rate).
(2) 제조공정(2) manufacturing process
본 실험에 사용한 일반 한과 강정은 찹쌀에 25% 알코올과 물을 첨가하여 10일간 침지하고, 분쇄기를 이용하여 80 mesh로 3회 반복 분쇄한 후 85℃에서 15분간 증자하였다. 이때 수분은 콩물로만 조절하고 수분함량이 48% 내외가 되도록 하였다. 증자된 반죽을 75rpm에서 꽈리치기를 하고 1×4×0.5 cm 정도의 크기로 절단한 후 1차 건조는 10~12시간 태양건조, 2차 건조는 건조실에서 40~45℃로 12시간 실시하였다. 튀김 온도 1단 150℃, 2단 180℃에서 콩기름으로 튀김하였다. 본 발명에 의한 홍삼 한과는 상기 실시예 1과 같이 제조하였다.
The general Korean and Kangjeong used in this experiment were immersed in glutinous rice for 25 days by adding 25% alcohol and water, and then pulverized three times with 80 mesh using a grinder and then steamed at 85 ° C. for 15 minutes. At this time, the moisture was controlled only with soy water and the water content was about 48%. The steamed dough was crushed at 75rpm, cut into 1 × 4 × 0.5 cm, and the first drying was carried out at 10-12 hours in sun drying and the second drying at 40-45 ° C. in a drying room for 12 hours. The frying temperature was fried with soybean oil at 1 stage 150 캜 and 2 stage 180 캜. Korean red ginseng according to the present invention was prepared as in Example 1.
(3) 산화안정성 실험방법(3) Oxidation Stability Test Method
1) Rancimat을 이용한 AOM(Active Oxygen Method) 측정1) Measurement of AOM (Active Oxygen Method) using Rancimat
추출한 유지의 산화 정도를 Rancimat 743(Methrohm, Switzerland)을 이용해 AOM을 측정하였다. 반응용기에 추출한 유지 3g을 취한 후 116±0.1℃에서 공기를 20ℓ/h의 속도로 주입하면서 측정하였으며 전기전도도의 변화에 따라서 자동적으로 산출되는 유도기간으로 항산화력을 나타내었다.The oxidation degree of the extracted oil was measured by AOM using Rancimat 743 (Methrohm, Switzerland). After taking 3g of the extracted oil and oil into the reaction vessel, air was injected at a rate of 20ℓ / h at 116 ± 0.1 ℃, and the antioxidant activity was shown as the induction period automatically calculated according to the change of electrical conductivity.
2) Acid value 측정2) Acid value measurement
추출 기름 1g을 취하여 ethyl ether-ethanol(2:1) 혼합액 100㎖을 가하고 1% 페놀프탈레인을 지시약으로 하여 알코올성 0.1N-KOH 용액으로 적정하였다.1 g of extracted oil was added and 100 ml of ethyl ether-ethanol (2: 1) mixed solution was added thereto, and titrated with alcoholic 0.1N-KOH solution using 1% phenolphthalein as an indicator.
3) Peroxide value 측정3) Peroxide value measurement
추출 기름 1g에 acetic acid : chloroform(3:2) 혼합액을 25㎖ 가하여 용해하고 KI 포화용액 0.5㎖를 가한 다음 진탕하여 10분간 방치한 후 증류수 100㎖를 가하여 충분히 진탕하고 전분용액을 지시약으로 하여 0.01N Na2S2O3용액으로 적정하였다.25 ml of acetic acid: chloroform (3: 2) mixture was added to 1 g of extracted oil, dissolved with 0.5 ml of saturated KI solution, shaken and left for 10 minutes, and 100 ml of distilled water was added. Titration with N Na 2 S 2 O 3 solution.
4) Thiobarbituric acid 측정4) Thiobarbituric acid measurement
추출 기름 3.0g을 삼각 플라스크에 정확히 취하고 벤젠 10㎖를 가하여 유지를 잘 용해한 다음 TBA 시약 10㎖를 가하고 4분간 진탕하고 방치한 다음 분액깔때기에 옮기고 정치하여 두 층으로 분리한 다음 끓는 물속에서 30분간 가열하였다. 냉각 후 분광광도계로 530nm에서 측정하여 100을 곱하여 TBA 값으로 표시하였다.
3.0 g of the extracted oil is precisely taken into an Erlenmeyer flask, and 10 ml of benzene is added to dissolve the fats and oils. 10 ml of TBA reagent is added, shaken and left for 4 minutes, transferred to a separatory funnel, and left to separate into two layers, followed by 30 minutes in boiling water. Heated. After cooling, measured at 530 nm with a spectrophotometer, multiplied by 100, and expressed as a TBA value.
(4) 산화안정성 측정결과(4) Oxidation stability measurement results
1) Rancimat을 이용한 AOM(Active Oxygen Method) 측정1) Measurement of AOM (Active Oxygen Method) using Rancimat
도 2에 도시한 바와 같이, 일반 한과에 비하여 본 발명의 제조방법에 의한 홍삼 한과의 유도기간이 증가한 것을 알 수 있었다. 이는 홍삼 쌀 조청물에 포함된 홍삼 성분이 한과에 있어서 항산화제 역할을 한 것임을 알 수 있었다. 특히 한과의 경우 전통식품에 홍삼 성분이 첨가되면 홍삼의 유효성분을 섭취할 수 있으므로 건강증진 효과뿐만 아니라 홍삼의 풍미로 인하여 소비자들의 거부감을 줄이고 산화안정성 효과도 유지할 수 있을 것이다.As shown in Figure 2, it was found that the induction period of the red ginseng confectionery by the manufacturing method of the present invention was increased compared to the general confection. It was found that the red ginseng component contained in the red ginseng rice syrup was an antioxidant in the Korean family. In particular, if the Korean ginseng is added to the traditional food, the red ginseng component can be consumed as an active ingredient of red ginseng, thereby improving consumer health and maintaining oxidative stability due to the flavor of red ginseng.
2) Acid value 측정2) Acid value measurement
식품위생규격 및 전통식품 표준규격에서 정한 유가류에 대한 산가의 기준치는 2.0mg/g인데, 도 2에 도시한 바와 같이, 일반 한과의 산가는 30일부터 급상승하고 본 발명에 의한 홍삼 한과에서는 60일까지 안정함을 알 수 있었다. 또한 본 발명에 의한 홍삼 한과의 산가가 일반 한과에 비하여 훨씬 낮은 수치를 보여 항산화 효과가 있음을 보여주었다. The standard value of the acid value for the oil value determined in the food hygiene standard and the standard food standard standard is 2.0mg / g, as shown in Figure 2, the acid value of the general Korean fare soaring from 30 days and 60 in the red ginseng Korean It was found to be stable until work. In addition, the acid value of the red ginseng Korean medicinal herb according to the present invention showed much lower values than the general medicinal herb, indicating that it has an antioxidant effect.
3) Peroxide value 측정3) Peroxide value measurement
도 2에 도시한 바와 같이, 본 발명에 의한 홍삼 한과와 일반 한과는 저장기간 30일에 과산화물가가 40meq/kg에 도달하였으나, 저장기간이 길어질수록 일반 한과의 과산화물가는 급격히 증가하였다. 반면, 본 발명에 의한 홍삼 한과의 저장기간이 더 증가한 것으로 보아 본 발명에 의한 홍삼 한과의 경우 홍삼의 항산화효과에 의하여 저장기간이 연장되는 효과를 보임을 알 수 있었다. As shown in FIG. 2, the peroxide value of the red ginseng and the common Korean confectionery according to the present invention reached 40 meq / kg in a storage period of 30 days, but the peroxide value of the common Korean confectionery increased rapidly as the storage period increased. On the other hand, since the storage period of the red ginseng confectionery according to the present invention was further increased, the red ginseng confectionery according to the present invention showed an effect of extending the storage period due to the antioxidant effect of red ginseng.
4) Thiobarbituric acid 측정4) Thiobarbituric acid measurement
TBA 값은 유지 속의 과산화물이 고온처리를 받을 때 생성되는 malon aldehyde 양을 나타내는 값으로, 도 2에 도시한 바와 같이, TBA 값은 본 발명에 의한 홍삼 한과가 일반 한과에 비해 약간 낮은 경향을 보였다. 이는 본 발명에 의한 홍삼 한과에 포함된 홍삼의 유효성분에 의한 항산화효과 때문인 것으로 판단되었다.
The TBA value represents the amount of malon aldehyde produced when the peroxide in the oil is subjected to high temperature treatment. As shown in FIG. 2, the TBA value of the red ginseng berry according to the present invention tended to be slightly lower than that of the common berry. This was judged to be due to the antioxidant effect of the active ingredient of red ginseng contained in the red ginseng Korean family according to the present invention.
실험예Experimental Example
5 : 홍삼의 지표성분인 5: index component of red ginseng
AFAF
((
ArginylArginyl
--
fructosefructose
) 및 AFG() And AFG (
ArginylArginyl
--
fructosylfructosyl
-glucose) 성분의 성기능 개선효과 실험Test of Sexual Function Improvement Effect of -glucose)
수삼을 증숙하고 건조하면 그 안의 당과 아미노산이 결합하여 비효소적 갈변반응인 Maillard reaction 반응이 일어나는데 이는 인삼의 2%를 차지하는 유리 아미노산 중 60-70 %를 차지하고 있는 arginine과 maltose가 반응한 것이다. 이러한 반응을 거쳐 amadori compound를 생성하며, 이렇게 생성되는 amadori compound에는 AF, AFG 등이 있다. Arginine-fructose-glucose가 결합한 arginine 유도체인 AFG는 갈색화 반응의 결과로 생성되는 물질로 ginsenoside와는 전혀 다른 아미노산 유도체인 것으로 알려져 있고 항산화, 항당뇨, 항비만 효과 등의 생리활성이 보고되고 있다. 홍삼에 5.37% 정도 함유되어 있는 것으로 보고된 바 있고 여기서 glucose 가 떨어진 형태가 바로 AF이다.When steamed and dried ginseng, the sugar and amino acids in it combine to produce a non-enzymatic browning reaction called Maillard reaction, which is the reaction between arginine and maltose, which account for 60-70% of free amino acids, which make up 2% of ginseng. Through this reaction, an amadori compound is produced, and the amadori compound thus produced includes AF and AFG. Arginine-fructose-glucose-bound arginine derivatives, AFGs, are the result of browning reactions and are known to be completely different amino acid derivatives from ginsenosides. It has been reported that red ginseng contains about 5.37%, and the form of glucose dropped here is AF.
본 실험에서는 홍삼의 활성성분인 AF와 AFG의 발기부전에 대한 개선효과를 동물실험을 통하여 확인하였다.
In this experiment, the effects of AF and AFG on the erectile dysfunction of red ginseng were confirmed through animal experiments.
(1) 동물모델을 통한 AF 및 AFG의 발기부전 예방 효과 실험방법
(1) Experimental method for preventing erectile dysfunction of AF and AFG through animal model
1) 실험동물의 사육 및 식이1) Breeding and diet of experimental animals
생후 8주령의 수컷 Sprague-Dawley (SD) rat을 (주)오리엔트로부터 구입하여 고형사료 (삼양사료)를 먹이면서 3일간 환경에 적응시킨 후 체중에 따라 난괴법으로 6군 대조군 (saline), Viagra® (1.7 mg/kg/day), AFG (200 and 400 mg/kg/day), BGE(흑삼추출물, 400 mg/kg/day)로 분리하였다. 오전과 오후 2회로 나누어 7일간 경구투여 하였으며 식이 섭취량은 매일 오전 9-10시 정해진 시간에 측정하였다. 사육장은 인공조명에 의하여 조명시간을 아침 8시부터 저녁 8시까지 12시간으로 조절하였으며 실내온도는 20 ± 3℃로 유지하였다. 급수는 정수된 일반 식수를 사용하였으며 사료는 일반 고형식이(삼양사료)를 공급하였다. 사료와 급수는 제한하지 않았으며 매일 오전 9-10시 정해진 시간에 공급해 주었다.Male Sprague-Dawley (SD) rats, 8 weeks old, were purchased from Orient Co., Ltd. ® (1.7 mg / kg / day), AFG (200 and 400 mg / kg / day), BGE (black ginseng extract, 400 mg / kg / day). Oral administration was divided into two sessions, morning and afternoon, for 7 days, and dietary intake was measured at a time of 9-10 am daily. The aviary was controlled by artificial lighting to adjust the lighting time from 8 am to 8 pm for 12 hours, and kept the room temperature at 20 ± 3 ℃. Water was used as purified drinking water, and feed was supplied with Samyang Feed. The feed and water supply were not restricted and were provided daily at a time of 9-10 am.
2) 조직의 채취2) collection of tissue
사육기간 종료 후 12시간 절식시킨 실험동물을 4% hydrochloride로 마취한 후 하복부를 개복하여 음경 조직을 적출하였다. 적출한 음경 조직은 요도를 제거한 후 PBS (pH 7.2)로 씻어 혈액을 제거시켰다. 혈액이 제거된 조직은 액체 질소로 급속 동결하여 -70℃에 보관하였다. 채취된 조직은 사용 전까지 -70℃에 보관하며 사용하였다. The animals fasted 12 hours after the end of the breeding period were anesthetized with 4% hydrochloride, and the lower abdomen was opened. The extracted penile tissues were removed with urethra and washed with PBS (pH 7.2) to remove blood. The blood removed tissues were rapidly frozen with liquid nitrogen and stored at -70 ° C. The collected tissue was stored at -70 ℃ until use.
3) Immuno blot을 이용한 nNOS, eNOS의 발현3) Expression of nNOS and eNOS using Immuno blot
액체 질소를 부어주면서 조직을 재빨리 분쇄하여 50 mM Tris-HCl, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM NaF, 1 mg/mL aprotinin, 1 mg/mL leupeptin,및 1 mg/mL pepstatin가 포함된 RIPA lysis buffer(pH 7.4)로 protein을 추출하였다. 추출한 protein은 bio-rad protein assay kit을 이용해 protein을 정량하여 30 그리고 40 μg의 protein을 8% acrylamide gel에서 2시간 동안 SDS-PAGE를 이용해 분리한 후 nitrocelluloase membrane으로 transfer하여 2% BSA를 이용해 blocking을 하였다. Protein의 1차 항체 (nNOS-1:1000, eNOS-1:500)와 4℃에서 12시간 동안 반응시킨 후 TBST (pH 8.0)로 15분 간격으로 1시간 30분 씻어주었다. 그 후 2차 항체 (rabbit 1:30000, mouse 1:15000)로 상온에서 1시간 반응시킨 다음 TBST(pH 8.0)로 15분 간격으로 1시간 30분동안 씻어준 후 chemiluminescent HRP substrate(ECL)로 감광시켜 image analyzer(Ras-4000 mini; Fujifilm, Japan)로 측정하였고 발현된 protein의 density는 multi gauge 3.1(Fujifilm, Japan) 프로그램을 이용하여 분석하였다.Quickly crush the tissue while pouring liquid nitrogen, 50 mM Tris-HCl, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM NaF, 1 mg Protein was extracted with RIPA lysis buffer (pH 7.4) containing / mL aprotinin, 1 mg / mL leupeptin, and 1 mg / mL pepstatin. The extracted protein was quantified using a bio-rad protein assay kit, and 30 and 40 μg of protein was separated from 8% acrylamide gel using SDS-PAGE for 2 hours, transferred to nitrocelluloase membrane, and blocked using 2% BSA. It was. After reacting with protein primary antibodies (nNOS-1: 1000, eNOS-1: 500) for 12 hours at 4 ℃ and washed with TBST (pH 8.0) for 1
4) 산화질소의 생성4) Production of Nitric Oxide
액체 질소를 부어주면서 조직을 재빨리 분쇄한 뒤 5 μM FMN, 0.1 mM NADPH, 20 μM BH4, 5 mM MgCl2과 10 mM arginine가 포함된 500 μL의 20mM Tris-HCl buffer (pH 7.2)와 DMSO에 녹인 20 μM의 DAF-FM을 섞어 37℃에서 15분간 반응시킨 후 5분간 10,000g에서 원심분리하여 상등액을 분석에 사용하였다. 상등액 200 μL를 fluorescence reader (TECAN Trading AG, Switzerland)를 이용해 excitation wavelength 485 nm, emission wavelength 535 nm에서 DAF의 fluorescence intensity를 측정하였다.Rapidly crush the tissue with liquid nitrogen and pour in 500 μL of 20 mM Tris-HCl buffer (pH 7.2) containing 5 μM FMN, 0.1 mM NADPH, 20 μM BH 4 , 5 mM MgCl 2 and 10 mM arginine and DMSO. 20 μM of dissolved DAF-FM was mixed and reacted at 37 ° C. for 15 minutes, followed by centrifugation at 10,000 g for 5 minutes, and the supernatant was used for analysis. 200 μL of the supernatant was measured using a fluorescence reader (TECAN Trading AG, Switzerland) to measure the fluorescence intensity of DAF at excitation wavelength 485 nm and emission wavelength 535 nm.
5) cGMP level5) cGMP level
액체 질소를 부어주면서 조직을 재빨리 분쇄한 뒤 0.1 mM CaCl2가 포함된 20 mM Tris-HCl buffer (pH 7.2)에 녹인 20 μM의 zaprinast를 37℃에서 2시간 처리하였다. 그 다음 5 μM FMN, 0.1 mM NADPH, 20 μM BH4, 5 mM MgCl2, 5mM GTP, 1 mM 3-isobutyl-1-methylxanthine, 0.75mM DL-dithiothreitol과 10 mM arginine이 포함된 500 μL의 20 mM Tris-HCl buffer (pH 7.2)를 37℃에서 15분간 반응시킨 후 5분간 10,000g에서 centrifuge하여 상등액을 분석에 사용하였다. 0.8-50 pM의 cGMP를 이용하여 standard curve를 작성한 다음 assay designs사의 cGMP ELISA kit을 이용해 cGMP 농도를 측정하였다.
The tissue was quickly crushed while pouring liquid nitrogen, and 20 μM zaprinast dissolved in 20 mM Tris-HCl buffer (pH 7.2) containing 0.1 mM CaCl 2 was treated at 37 ° C. for 2 hours. Then 500 μL of 20 mM containing 5 μM FMN, 0.1 mM NADPH, 20 μM BH 4 , 5 mM MgCl 2 , 5 mM GTP, 1 mM 3-isobutyl-1-methylxanthine, 0.75 mM DL-dithiothreitol and 10 mM arginine Tris-HCl buffer (pH 7.2) was reacted at 37 ° C. for 15 minutes, and then centrifuge at 10,000 g for 5 minutes to use the supernatant for analysis. Standard curves were prepared using cGMP at 0.8-50 pM, and cGMP concentrations were measured using cGMP ELISA kit of assay designs.
(2) 발기부전 예방 효과 분석결과
(2) Analysis result of erectile dysfunction prevention
1) nNOS 및 eNOS 발현 분석결과1) nNOS and eNOS expression analysis results
실험동물의 해면체 조직을 분리하여 nNOS 및 eNOS의 발현을 측정한 결과는 도 4에 나타내었다. AFG는 200 및 400 μg/kg 투여에서 농도 의존적으로 nNOS 및 eNOS의 발현을 증가시킨 것을 알 수 있었다. nNOS의 경우 AFG (400 μg/kg) > BGE (흑삼추출물) > Viagra®> AFG (200 μg/kg) 순서로 발현이 증가하였으며, eNOS는 AFG (400 μg/kg) > AFG (200 μg/kg) > BGE (흑삼추출물) > Viagra® 순으로 발현이 증가하였다. 이 결과는 AFG가 eNOS 및 nNOS의 발현을 증가시켜 NO의 생성을 증가시킬 수 있음을 시사한다. 또한, 발기부전 치료제로 잘 알려진 Viagra®의 경우 NOS가 많이 증가하지 않음을 알 수 있는데 이것은 Viagra®가 PGE-5를 선택적으로 억제하고 차단하는 것으로 알려진 것처럼 NOS에는 크게 영향을 미치지 않는 것으로 추정된다. AFG는 eNOS 및 nNOS의 발현을 통해 발기부전을 예방할 수 있는 좋은 건강기능식품 소재라 여겨진다.The result of measuring the expression of nNOS and eNOS by separating the cavernous tissue of the experimental animal is shown in FIG. AFG was found to increase the expression of nNOS and eNOS concentration-dependently at 200 and 400 μg / kg administration. For nNOS, expression increased in the order of AFG (400 μg / kg)> BGE (black ginseng extract)> Viagra ® > AFG (200 μg / kg), eNOS showed AFG (400 μg / kg)> AFG (200 μg / kg) )> BGE (black ginseng extract)> Viagra ® increased expression. This result suggests that AFG can increase the production of NO by increasing the expression of eNOS and nNOS. In addition, Viagra ® , which is known as an erectile dysfunction treatment agent, does not increase NOS. It is estimated that Viagra ® does not significantly affect NOS as it is known to selectively inhibit and block PGE-5. AFG is considered a good dietary supplement that can prevent erectile dysfunction through the expression of eNOS and nNOS.
2) 산화질소 생성 분석결과2) Nitrogen oxide production analysis result
실험동물의 해면체 조직에서 NO 생성을 분석한 결과는 도 4에 나타내었다. AFG는 200 그리고 400μg/kg 투여에서 농도 의존적으로 NO 생성을 증가시켰다. eNOS의 발현은 NO 생성과 유사한 결과를 나타냈다. 이 결과로부터 AFG에 의해 내피세포에서 발현된 eNOS는 NO 생성에 긍정적으로 기여하였음을 알 수 있다. The results of analysis of NO production in the cavernous tissue of the experimental animals are shown in FIG. 4. AFG increased NO production in a dose dependent manner at 200 and 400 μg / kg doses. Expression of eNOS gave similar results to NO production. From these results, it can be seen that eNOS expressed in endothelial cells by AFG contributed positively to NO production.
3) cGMP level 분석3) cGMP level analysis
도 5에 도시한 바와 같이, Viagra®를 투여한 군은 PDE-5의 저해로 cGMP 농도가 control군에 비해 약 18배 이상 증가한 것을 알 수 있었다. AFG는 200 및 400㎛에서 농도 의존적으로 cGMP를 증가시켰으며 400㎛의 AFG는 control군에 비해 cGMP 농도를 6배 증가시킨 것을 알 수 있었다. 여기서 AFG와 Viagra® 의 cGMP 생성량이 2배 이상 차이가 나는 이유는 Viagra®는 인위적으로 PDE-5 생성 단계를 차단하여 생성된 cGMP가 장기간 음경 해면체에 머물러 있도록 하여 발기를 유지시키는 반면, AFG는 eNOS와 nNOS에 의해 NO 생성을 증가시킨 후 sGC를 활성화시켜 GTP를 cGMP로 전환시키는 단계를 거치고 cGMP가 발생한 이후에도 PDE-5가 생성되어 cGMP의 level이 자연스럽게 낮아지게 하면서 전체적인 활성을 촉진시켜 발기를 조절하기 때문으로 해석된다. 결국 AFG에 의해 발현이 증가된 eNOS와 nNOS는 NO의 생성을 증가시키는 원인이 되고 증가된 NO는 해면체 평활근 세포로 들어가 sGC를 활성화시켜 cGMP의 level을 증가시키는 것으로 추측된다. As shown in FIG. 5, the group administered Viagra ® was found to have increased cGMP concentration by about 18 times more than the control group due to inhibition of PDE-5. AFG increased cGMP concentration-dependently at 200 and 400 μm, and AFG of 400 μm increased cGMP concentration 6-fold compared to the control group. Here, while that is why the cGMP production is more than twice the difference between AFG and Viagra ®, I have Viagra ® is a cGMP produced by artificially blocking the PDE-5 generation step maintaining an erection by allowing remained in long-term corpus cavernosum, AFG is eNOS And increase NO production by nNOS and then activate sGC to convert GTP to cGMP, and even after cGMP occurs, PDE-5 is produced to lower overall levels of cGMP while promoting overall activity to regulate erection. It is interpreted because. In conclusion, eNOS and nNOS with increased expression by AFG are responsible for increasing NO production, and increased NO enters cavernous smooth muscle cells and activates sGC to increase the level of cGMP.
심장병 약 등 다른 약과 함께 복용할 경우 혈압 급강하 현상을 초래하는 등의 Viagra® 의 부작용을 경감시키고 보완할 수 있는 천연 소재로 Viagra®와는 다른 작용기전으로 eNOS 등의 효소작용을 증진시키는 우수성을 가지는 AFG와 같은 홍삼의 갈변물질 등이 대안이 될 수 있을 것이다.
AFG, which is a natural material that can alleviate and compensate for the side effects of Viagra ® , such as blood pressure drop when taken with other medicines such as heart disease drugs, has a superior function of enhancing enzyme activity such as eNOS as a mechanism of action different from Viagra ®. Browning materials such as red ginseng may be an alternative.
이상으로 본 발명의 특정한 부분을 상세히 기술한바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현 예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.As described above in detail specific parts of the present invention, it is apparent to those skilled in the art that these specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. Thus, the substantial scope of the present invention will be defined by the appended claims and equivalents thereof.
Claims (6)
상기 찹쌀분말에 콩물을 찹쌀분말 중량대비 1 내지 3%를 첨가하고, 최종 수분함량이 15 내지 25 %가 되도록 물을 첨가하여 반죽하여 반죽물을 형성하는 단계(제2단계);
상기 반죽물을 증숙시켜 증숙물을 제조한 후, 이를 반죽기에 넣고 꽈리치기한 뒤, 반대기 성형을 하여 반대기를 제조하는 단계(제3단계);
상기 반대기를 건조시킨 후, 숙성시킨 뒤 기름으로 튀겨내어 튀긴 반대기를 제조하는 단계(제4단계);
전통조청과 당액을 중량대비 1 : 0.1 내지 0.3으로 혼합하여 제조한 조청시럽을 상기 전처리한 인삼에 중량대비 4 내지 6 : 1로 첨가한 후 90 내지 100℃에서 3 내지 12시간 졸여 78 Brix 이상이 되도록 홍삼 쌀 조청물을 제조하는 단계(제5단계); 및
상기 제조된 홍삼 쌀 조청물과 전통 쌀 조청을 중량 대비 100 내지 60% : 0 내지 40% 비율로 혼합하여 당도가 78 Brix 이상이 될 때까지 졸인 다음 상기 튀긴 반대기에 골고루 묻힌 다음, 반대기 전체에 튀밥을 묻혀 홍삼 한과를 제조하는 단계로 이루어진 것을 특징으로 하는 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법.
Ginseng is screened, washed and pre-treated, the glutinous rice is soaked in water and then fermented to produce a glutinous rice fermented product and then dehydrated and milled to prepare a glutinous rice powder (first step);
Adding 1 to 3% of the soybean water to the glutinous rice powder to the glutinous rice powder and kneading by adding water so that the final moisture content is 15 to 25% (second step);
Preparing a steamed product by steaming the dough, putting it in a dough machine, and then preparing a counter machine by forming a counter machine (third step);
Drying the counterpart, then aging and frying with oil to prepare a fried counterpart (fourth step);
After adding the crude syrup prepared by mixing the traditional crude syrup and the sugar solution in a ratio of 1: 0.1 to 0.3 by weight to the pretreated ginseng in a ratio of 4 to 6: 1 by weight, it was boiled at 90 to 100 ° C. for 3 to 12 hours and 78 Brix or more. Preparing a red ginseng rice syrup (5th step); And
The prepared red ginseng rice syrup and traditional rice syrup are mixed at a ratio of 100 to 60%: 0 to 40% by weight, and then boiled until the sugar content is 78 Brix or more, and then evenly buried in the fried counterpart, Method for producing red ginseng Korean confection using red ginseng rice syrup, comprising the steps of preparing red ginseng confectionery buried with rice.
제1단계에서 찹쌀분말 제조시, 물에 찹쌀을 수침시킨 후, 22 내지 27 ℃에서 3 내지 7일 동안 발효시켜 찹쌀 발효물을 제조한 후, 탈수시킨 다음 분쇄기로 분쇄하여 제조하는 것을 특징으로 하는 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법.
The method of claim 1,
When manufacturing the glutinous rice powder in the first step, after immersing the glutinous rice in water, fermented for 3 to 7 days at 22 to 27 ℃ to prepare the glutinous rice fermented product, it is dehydrated and then pulverized by grinding A method of preparing red ginseng Korean fruit using red ginseng rice syrup.
제4단계의 튀긴 반대기 제조시, 반대기를 1 차로 10 내지 12 시간 자연건조한 다음, 40 내지 45 ℃에서 12 내지 16 시간 동안 2차 건조하여 최종 수분함량이 14 %로 유지되도록 한 후, 12 내지 18 ℃에서 10 내지 15일 동안 숙성시킨 뒤, 튀겨내어 튀긴 반대기를 제조하는 것을 특징으로 하는 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법.
The method of claim 1,
In the preparation of the fried counterpart of the fourth step, the counterpart is naturally dried for 10 to 12 hours first, and then secondly dried at 40 to 45 ° C. for 12 to 16 hours to maintain a final water content of 14%, followed by 12 to After ripening for 10 to 15 days at 18 ℃, a method of manufacturing red ginseng Korean confection using red ginseng rice syrup, characterized in that to prepare a fried counter-fry.
상기 제5단계에서 당액은 포도당, 과당, 말토오스, 자당, 락토오스, 자일리톨 중 어느 하나 또는 둘 이상을 혼합하여 사용하는 것을 특징으로 하는 홍삼 쌀 조청물을 이용한 홍삼 한과의 제조방법.
The method of claim 1,
In the fifth step, the sugar solution is a method of producing red ginseng Korean confection using red ginseng rice syrup, characterized in that any one or two or more of glucose, fructose, maltose, sucrose, lactose and xylitol are used in combination.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110071360A KR101083524B1 (en) | 2011-07-19 | 2011-07-19 | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110071360A KR101083524B1 (en) | 2011-07-19 | 2011-07-19 | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101083524B1 true KR101083524B1 (en) | 2011-11-16 |
Family
ID=45397725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110071360A KR101083524B1 (en) | 2011-07-19 | 2011-07-19 | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101083524B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101517757B1 (en) | 2013-09-17 | 2015-05-06 | 전영민 | Producing method for grilled Korean traditional sweets and fruit. |
KR20160077782A (en) | 2014-12-24 | 2016-07-04 | 김주희 | Manufacturing method for korean traditional cookie having grain |
KR101638295B1 (en) | 2015-11-13 | 2016-07-08 | 한국참생약영농조합법인 | Method for manufacturing dried up fruits of red ginseng and dried up fruits of red ginseng manufactured by thereof |
KR101996189B1 (en) | 2018-12-03 | 2019-07-04 | 김갑진 | Traditional Cookie Base Drying Apparatus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100773809B1 (en) * | 2007-08-13 | 2007-11-06 | 김현례 | Process for manufacturing red ginseng korean cookie using white ginseng and red ginseng extraction liquid |
-
2011
- 2011-07-19 KR KR1020110071360A patent/KR101083524B1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100773809B1 (en) * | 2007-08-13 | 2007-11-06 | 김현례 | Process for manufacturing red ginseng korean cookie using white ginseng and red ginseng extraction liquid |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101517757B1 (en) | 2013-09-17 | 2015-05-06 | 전영민 | Producing method for grilled Korean traditional sweets and fruit. |
KR20160077782A (en) | 2014-12-24 | 2016-07-04 | 김주희 | Manufacturing method for korean traditional cookie having grain |
KR101638295B1 (en) | 2015-11-13 | 2016-07-08 | 한국참생약영농조합법인 | Method for manufacturing dried up fruits of red ginseng and dried up fruits of red ginseng manufactured by thereof |
KR101996189B1 (en) | 2018-12-03 | 2019-07-04 | 김갑진 | Traditional Cookie Base Drying Apparatus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100935847B1 (en) | Manufacturing method for the slice of red ginseng | |
CN104824528A (en) | Blood nourishing and essence strengthening health paste preparation method | |
CN102228180A (en) | Betelnut buccal tablet and preparation method thereof | |
KR101102578B1 (en) | Method producing functional vinegar picked egg and functional vinegar picked egg produced by the same method | |
KR20140103622A (en) | The method for manufacturing functional tea product made from onion skin, and the product made by the method | |
KR101134542B1 (en) | Process for manufacturing red ginseng jung kwa and slice using plum extract | |
KR101083524B1 (en) | Process for manufacturing red ginseng korean sweets and cookies using red ginseng rice syrup | |
KR20030026939A (en) | The effective tea compositions with guava leaf as chief element for remedy against diabetes, obesity and aging, and functional foods | |
KR101181920B1 (en) | Common conger drink and method thereof | |
KR100976241B1 (en) | Extract of sedum sarmentosum for alcohol oxidation and relieves hangover | |
CN105660958A (en) | Preparation method of lotus leaf and lotus seed tea | |
CN103478560B (en) | Nutrition rice prepared through milk and gynostemma pentaphylla | |
KR102070507B1 (en) | Manufacturing method for samgyetang using black ginseng and samgyetang using black ginseng manufactured by the same | |
KR100855665B1 (en) | Kochujang for anti-cholesterol comprising persimmon fruit and extracts of herb medicine mixture and a preparation method thereof | |
KR102002080B1 (en) | Method for producing glutinous rice cake using persimmon, grain and medicinal plant | |
KR101962766B1 (en) | Improving method for bitter taste of bitter gourd liquid tea and preparing method for bitter taste improved bitter gourd liquid tea using the same | |
KR101162581B1 (en) | Dried Persimmon Having Good Functionality and Method for Preparing the Same | |
KR101438548B1 (en) | Improved taste of a colored traditional Korean Snack containing mulberry powder and process for preparation thereof | |
KR20100079646A (en) | Korean hot pepper paste for red ginseng marc and the producing method thereof | |
KR20070047396A (en) | A functional beverage using hericium erinaceus extracts and manufacturing process of the same | |
KR20220042707A (en) | Method for manufacturing red ginseng Korean confection with improved functionality and flavor using red ginseng rice syrup | |
KR101668447B1 (en) | Composition for curing hanover and health functional foods composition comprising the same | |
KR100505780B1 (en) | Healthy food composition having efficacy of anti-diabetic and its process | |
CN111096344A (en) | Sandwich biscuit with function of relieving alcoholic liver injury and preparation method thereof | |
KR101917009B1 (en) | Method of Making Instant Soy Bean Soup Comprising Chrysanthemum zaqadskii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140828 Year of fee payment: 4 |
|
LAPS | Lapse due to unpaid annual fee |